Skip to main content
. Author manuscript; available in PMC: 2020 Jun 30.
Published in final edited form as: Methods Mol Biol. 2017;1677:1–80. doi: 10.1007/978-1-4939-7321-7_1

Table 3.

Summary of GluN2C/D-selective modulators.

Activity at GluN1/2X (in μM)
Compound 2A 2B 2C 2D
PBPD graphic file with name nihms-1600275-t0013.jpg Kie 15.8 5.0 9.0 4.3 [375]
PPDA graphic file with name nihms-1600275-t0014.jpg Kie 0.55 0.31 0.096 0.125 [374]
UBP141 graphic file with name nihms-1600275-t0015.jpg Kie 14.2 19.3 4.2 2.8 [376]
QNZ-46 graphic file with name nihms-1600275-t0016.jpg IC50 229
182
ND
193
6
7.1
3
3.9
[383]
[384]
DQP-1105 graphic file with name nihms-1600275-t0017.jpg IC50 ND 113 7.0 2.7 [385]
CIQ, (+)-CIQ* graphic file with name nihms-1600275-t0018.jpg EC50 NE NE 2.7,
9.0
2.8,
8.0
[390]
[391,392]
PYD-106 graphic file with name nihms-1600275-t0019.jpg EC50 NE NE 16 NE [160]

NE denotes no effect at the highest concentrations evaluated, and ND indicates that the compound displayed some activity, but the affinity or potency could not be determined. Unless otherwise stated (also denoted by ), the values were determined using two-electrode voltage-clamp experiments with Xenopus oocytes.

e

Ki values were estimated using Cheng-Prusoff correction of the measured IC50 values.

*

The chiral carbon of (+)-CIQ, the active enantiomer, is denoted by the asterisk in the chemical structure.

The apparent lower potency for (+)-CIQ compared to the racemic mixture is likely due to better estimation of maximum potentiation, since the active enantiomer has increased abundance in solution at concentrations close to the solubility limit (i.e the pure enantiomers can be evaluated at higher concentrations compared racemic CIQ).